EcoDrugPlus

Kinesin Family Member 11

Ensembl ID : ENSODEG00000006812
Gene Symbol: KIF11
3 Cross references
202 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSODEG00000003045
Gene Symbol: KIF5B
3 Cross references
280 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSODEG00000010622
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSODEG00000014755
Gene Symbol: KDM1A
3 Cross references
213 Possible Orthologues:

Lysyl Oxidase Like 2

Ensembl ID : ENSODEG00000006938
Gene Symbol: LOXL2
3 Cross references
287 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSODEG00000006630
Gene Symbol: MIF
3 Cross references
218 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSODEG00000012714
Gene Symbol: MMP12
3 Cross references
550 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSODEG00000012128
Gene Symbol: MMP13
3 Cross references
200 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSODEG00000001611
Gene Symbol: MMP14
3 Cross references
269 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSODEG00000004399
Gene Symbol: MMP2
2 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 3

Ensembl ID : ENSODEG00000012755
Gene Symbol: MMP3
3 Cross references
493 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSODEG00000012568
Gene Symbol: MMP7
3 Cross references
163 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).